MMP26
Basic information
Region (hg38): 11:4704784-4992431
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MMP26 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 15 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 208 | 23 | 233 | |||
Total | 0 | 0 | 223 | 26 | 2 |
Variants in MMP26
This is a list of pathogenic ClinVar variants found in the MMP26 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-4769013-C-T | not specified | Likely benign (Oct 03, 2022) | ||
11-4769034-C-T | not specified | Uncertain significance (Nov 07, 2023) | ||
11-4769059-G-C | not specified | Uncertain significance (Apr 13, 2022) | ||
11-4769100-A-C | not specified | Uncertain significance (Nov 22, 2023) | ||
11-4769116-G-A | not specified | Uncertain significance (May 17, 2023) | ||
11-4769124-C-T | not specified | Likely benign (Aug 22, 2023) | ||
11-4769272-T-C | not specified | Uncertain significance (Apr 12, 2024) | ||
11-4769325-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
11-4769331-G-T | not specified | Uncertain significance (Feb 22, 2023) | ||
11-4769392-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
11-4769442-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
11-4769460-C-A | not specified | Uncertain significance (Jan 23, 2023) | ||
11-4769461-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
11-4769560-T-G | not specified | Uncertain significance (Jan 03, 2024) | ||
11-4769625-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
11-4769643-CG-C | not specified | Benign (Mar 28, 2016) | ||
11-4769665-C-T | not specified | Uncertain significance (Jul 14, 2023) | ||
11-4769685-G-C | not specified | Uncertain significance (May 13, 2024) | ||
11-4769745-T-C | not specified | Uncertain significance (Apr 12, 2024) | ||
11-4769784-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
11-4769791-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
11-4769839-C-A | not specified | Uncertain significance (Jan 04, 2022) | ||
11-4769842-G-T | not specified | Uncertain significance (Dec 14, 2022) | ||
11-4769866-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
11-4769889-T-G | not specified | Uncertain significance (May 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MMP26 | protein_coding | protein_coding | ENST00000380390 | 6 | 287503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.36e-11 | 0.0322 | 125715 | 0 | 5 | 125720 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.228 | 149 | 141 | 1.05 | 0.00000681 | 1729 |
Missense in Polyphen | 37 | 36.213 | 1.0217 | 476 | ||
Synonymous | 0.360 | 52 | 55.4 | 0.938 | 0.00000315 | 477 |
Loss of Function | -0.341 | 15 | 13.6 | 1.10 | 5.82e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May hydrolyze collagen type IV, fibronectin, fibrinogen, beta-casein, type I gelatin and alpha-1 proteinase inhibitor. Is also able to activate progelatinase B.;
- Pathway
- Matrix Metalloproteinases
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.581
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.29
Haploinsufficiency Scores
- pHI
- 0.0344
- hipred
- N
- hipred_score
- 0.158
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.00000506
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- proteolysis;extracellular matrix organization;collagen catabolic process;negative regulation of inflammatory response
- Cellular component
- extracellular space;extracellular matrix
- Molecular function
- metalloendopeptidase activity;zinc ion binding